PMC:7435837 / 42003-42274
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T268 | 4-14 | Body_part | denotes | human body | http://purl.org/sig/ont/fma/fma305853 |
| T269 | 99-103 | Body_part | denotes | head | http://purl.org/sig/ont/fma/fma7154 |
| T270 | 192-196 | Body_part | denotes | body | http://purl.org/sig/ont/fma/fma256135 |
| T271 | 266-270 | Body_part | denotes | body | http://purl.org/sig/ont/fma/fma256135 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T23 | 99-103 | Body_part | denotes | head | http://purl.obolibrary.org/obo/UBERON_0000033 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T392 | 4-9 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T393 | 18-19 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T394 | 99-103 | http://purl.obolibrary.org/obo/UBERON_0000033 | denotes | head |
| T395 | 99-103 | http://www.ebi.ac.uk/efo/EFO_0000964 | denotes | head |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T527 | 42-46 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T528 | 60-64 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T33 | 200-211 | http://purl.obolibrary.org/obo/GO_0009056 | denotes | degradation |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 843 | 4-9 | Species | denotes | human | Tax:9606 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T320 | 0-107 | Sentence | denotes | The human body is a harsh environment and drug delivery and drug development meet these challenges head-on. |
| T321 | 108-271 | Sentence | denotes | These include, for example, resistance to absorption of therapeutic agents into the body or degradation of therapeutic agents once they are absorbed into the body. |